loader
Please Wait
Applying Filters...

Euroapi Company Header Euroapi Company Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Etrumadenant, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Etrumadenant

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

    One Pharma aims to be one of the leading generic companies in Europe.

    2D Structure
    1. Also known as: Ab928, 2239273-34-6, Ab-928, Etrumadenant, 3-(2-amino-6-(1-((6-(2-hydroxypropan-2-yl)pyridin-2-yl)methyl)-1h-1,2,3-triazol-4-yl)pyrimidin-4-yl)-2-methylbenzonitrile, Etrumadenant [usan]
    Molecular Formula
    C23H22N8O
    Molecular Weight
    426.5  g/mol
    InChI Key
    BUXIAWLTBSXYSW-UHFFFAOYSA-N
    FDA UNII
    W0ZE0NT8IF
    Etrumadenant is an orally bioavailable antagonist of both the immunomodulatory checkpoint molecules adenosine A2A receptor (A2AR; ADORA2A) and A2B receptor (A2BR; ADORA2B), with potential immunomodulating and antineoplastic activities. Upon administration, etrumadenant competes with tumor-released adenosine for binding to A2AR and A2BR expressed on numerous intra-tumoral immune cells, such as dendritic cells (DCs), natural killer (NK) cells, macrophages and T-lymphocytes. The binding of AB928 to A2AR and A2BR inhibits A2AR/A2BR activity and prevents adenosine-A2AR/A2BR-mediated signaling. A2AR/A2BR inhibition activates and enhances the proliferation of various immune cells, abrogates the adenosine-mediated immunosuppression in the tumor microenvironment (TME) and activates the immune system to exert anti-tumor immune responses against cancer cells, which leads to tumor cell killing. A2AR and A2BR, G protein-coupled signaling receptors, are expressed on the cell surfaces of numerous immune cells. Adenosine is often overproduced by tumor cells and plays a key role in immunosuppression and tumor cell proliferation.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    3-[2-amino-6-[1-[[6-(2-hydroxypropan-2-yl)pyridin-2-yl]methyl]triazol-4-yl]pyrimidin-4-yl]-2-methylbenzonitrile
    2.1.2 InChI
    InChI=1S/C23H22N8O/c1-14-15(11-24)6-4-8-17(14)18-10-19(28-22(25)27-18)20-13-31(30-29-20)12-16-7-5-9-21(26-16)23(2,3)32/h4-10,13,32H,12H2,1-3H3,(H2,25,27,28)
    2.1.3 InChI Key
    BUXIAWLTBSXYSW-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC1=C(C=CC=C1C2=CC(=NC(=N2)N)C3=CN(N=N3)CC4=NC(=CC=C4)C(C)(C)O)C#N
    2.2 Other Identifiers
    2.2.1 UNII
    W0ZE0NT8IF
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Ab928

    2. 2239273-34-6

    3. Ab-928

    4. Etrumadenant

    5. 3-(2-amino-6-(1-((6-(2-hydroxypropan-2-yl)pyridin-2-yl)methyl)-1h-1,2,3-triazol-4-yl)pyrimidin-4-yl)-2-methylbenzonitrile

    6. Etrumadenant [usan]

    7. W0ze0nt8if

    8. 3-[2-amino-6-[1-[[6-(1-hydroxy-1-methylethyl)-2-pyridinyl]methyl]-1h-1,2,3-triazol-4-yl]-4-pyrimidinyl]-2-methylbenzonitrile

    9. Trumadenant

    10. Unii-w0ze0nt8if

    11. A2ar/a2br Antagonist-1

    12. Etrumadenant [inn]

    13. Etrumadenant [who-dd]

    14. Chembl4740383

    15. Schembl20401465

    16. Gtpl11154

    17. Bcp33220

    18. Ex-a3172

    19. Mfcd32263040

    20. Nsc823658

    21. S9608

    22. Who 11620

    23. Zb1610

    24. Akos037649091

    25. Ab928 ; Ab 928

    26. Nsc-823658

    27. Ac-36346

    28. Bs-16547

    29. Hy-129393

    30. Cs-0105184

    31. D81385

    32. Q66977586

    33. Benzonitrile, 3-[2-amino-6-[1-[[6-(1-hydroxy-1-methylethyl)-2-pyridinyl]methyl]-1h-1,2,3-triazol-4-yl]-4-pyrimidinyl]-2-methyl-

    2.4 Create Date
    2018-12-15
    3 Chemical and Physical Properties
    Molecular Weight 426.5 g/mol
    Molecular Formula C23H22N8O
    XLogP31.4
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count8
    Rotatable Bond Count5
    Exact Mass426.19165736 g/mol
    Monoisotopic Mass426.19165736 g/mol
    Topological Polar Surface Area139 Ų
    Heavy Atom Count32
    Formal Charge0
    Complexity680
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    Post Enquiry
    POST ENQUIRY